Edition:
United Kingdom

ViewRay Inc (VRAY.OQ)

VRAY.OQ on NASDAQ Stock Exchange Global Market

8.41USD
16 Feb 2018
Change (% chg)

$0.03 (+0.36%)
Prev Close
$8.38
Open
$8.40
Day's High
$8.51
Day's Low
$8.26
Volume
123,283
Avg. Vol
203,102
52-wk High
$10.63
52-wk Low
$4.40

Chart for

About

No overview information found for .
No analyst recommendations are available for .

Overall

No Ratios Available.

Financials

  Industry Sector
P/E (TTM): -- 148.59 16.64
EPS (TTM): -- -- --
ROI: -- 9.38 10.66
ROE: -- 14.72 14.30

BRIEF-Viewray Announces Preliminary Q4 And Fiscal Year 2017 Results

* VIEWRAY ANNOUNCES PRELIMINARY FOURTH QUARTER AND FISCAL YEAR 2017 RESULTS

08 Jan 2018

BRIEF-Viewray Files For Resale By Selling Stockholders Of 6.7 Million Shares Of Co

* VIEWRAY INC FILES FOR RESALE BY SELLING STOCKHOLDERS OF 6.7 MILLION SHARES OF CO - SEC FILING Source text :[http://bit.ly/2Bp8yIs] Further company coverage:

22 Dec 2017

BRIEF-ViewRay Q3 loss per share $0.19

* Q3 earnings per share view $-0.12 -- Thomson Reuters I/B/E/S

13 Nov 2017

BRIEF-‍Fosun International Ltd reports a 9.91 pct passive stake in Viewray Inc

* ‍Fosun International Ltd reports a 9.91 percent passive stake in Viewray Inc as of Oct 24, 2017 - SEC filing​​ Source text: (http://bit.ly/2xTl0hH) Further company coverage:

03 Nov 2017

BRIEF-Viewray's unit enters into amendment no. 3 to term loan agreement​

* On October 9, unit of co entered into amendment no. 3 to term loan agreement​ - SEC filing

13 Oct 2017

BRIEF-ViewRay launches clinical trial for pancreatic cancer using MRIdian System

* ViewRay launches clinical trial following compelling early pancreatic cancer data with MRidian System Source text for Eikon: Further company coverage:

25 Sep 2017

Earnings vs. Estimates

No consensus analysis data available.